TuHURA Biosciences (HURA) Projected to Post Quarterly Earnings on Wednesday

TuHURA Biosciences (NASDAQ:HURA) is expected to be posting its earnings data before the market opens on Wednesday, February 12th. Analysts expect TuHURA Biosciences to post earnings of ($0.11) per share for the quarter.

TuHURA Biosciences Stock Up 0.6 %

NASDAQ HURA opened at $4.88 on Wednesday. TuHURA Biosciences has a one year low of $2.84 and a one year high of $14.60. The stock has a 50-day simple moving average of $4.81.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HURA. Maxim Group initiated coverage on shares of TuHURA Biosciences in a report on Tuesday, November 5th. They set a “buy” rating and a $15.00 price objective for the company. Rodman & Renshaw assumed coverage on shares of TuHURA Biosciences in a research note on Thursday, December 19th. They set a “buy” rating and a $11.00 target price for the company. Finally, RODMAN&RENSHAW upgraded TuHURA Biosciences to a “strong-buy” rating in a research note on Thursday, December 19th.

About TuHURA Biosciences

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. TuHURA’s lead innate immune response agonist candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors.